製薬における AI の世界市場機会と戦略

Report Description

AI In Pharma Market Opportunities and Strategies to 2032 from The Business Research Company provides the strategists; marketers and senior management with the critical information they need to assess the global AI in pharma market as it emerges from the COVID-19 shut down.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 12 geographies.
• Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market research findings.
• Benchmark performance against key competitors.
• Utilize the relationships between key data sets for superior strategizing.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis

Description:
Where is the largest and fastest-growing market for AI in pharma? How does the market relate to the overall economy; demography and other similar markets? What forces will shape the market going forward? The AI in pharma market global report from The Business Research Company answers all these questions and many more.
The report covers market characteristics; size and growth; segmentation; regional and country breakdowns; competitive landscape; market shares; trends and strategies for this market. It traces the market’s history and forecasts market growth by geography. It places the market within the context of the wider AI in pharma market; and compares it with other markets.

The report covers the following chapters

• Introduction And Market Characteristics – Brief introduction to the segmentations covered in the market, definitions and explanations about the segment by technology, by drug type and by application market.
• Key Trends – Highlights the major trends shaping the global market. This section also highlights likely future developments in the market.
• Macro-Economic Scenario – The report provides an analysis of the impact of the Russia-Ukraine war, impact of the COVID-19 pandemic and impact of rising inflation on global and regional markets, providing strategic insights for businesses in the AI in pharma market.
• Global Market Size And Growth – Global historic (2017-2022) and forecast (2022-2027, 2032F) market values, and drivers and restraints that support and control the growth of the market in the historic and forecast.
• Regional Analysis – Historic (2017-2022) and forecast (2022-2027, 2032F) market values and growth and market share comparison by region and country.
• Market Segmentation – Contains the market values (2017-2022) (2022-2027, 2032F) and analysis for each segment by technology, by drug type and by application in the market. Historic (2017-2022) and forecast (2022-2027), and (2027-2032) market values and growth and market share comparison by region market.
• Regional Market Size And Growth – Regional market size (2022), historic (2017-2022) and forecast (2022-2027, 2032F) market values, and growth and market share comparison of countries within the region. This report includes information on all the regions Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa and major countries within each region.
• Competitive Landscape – Details on the competitive landscape of the market, estimated market shares and company profiles of the leading players.
• Key Mergers And Acquisitions – Information on recent mergers and acquisitions in the market covered in the report. This section gives key financial details of mergers and acquisitions, which have shaped the market in recent years.
• Market Opportunities And Strategies – Describes market opportunities and strategies based on findings of the research, with information on growth opportunities across countries, segments and strategies to be followed in those markets.
• Conclusions And Recommendations – This section includes recommendations for AI in pharma providers in terms of product/service offerings geographic expansion, marketing strategies and target groups.
• Appendix – This section includes details on the NAICS codes covered, abbreviations and currencies codes used in this report.

Scope

Markets Covered:
1) By Technology: Context-Aware Processing; Natural Language Processing; Querying Method; Deep Learning
2) By Drug Type: Small Molecule; Large Molecules
3) By Application: Diagnosis; Clinical Trial Research; Drug Discovery; Research And Development; Epidemic Prediction

Companies Mentioned: Concerto HealthAI; Alphabet Inc; OWKIN; Nvidia Corporation and Path AI

Countries: China; Australia; India; Indonesia; Japan; South Korea; USA; Brazil; France; Germany; UK; Russia

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time-series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets; GDP proportions; expenditure per capita; AI in pharma indicators comparison.

Data segmentations: country and regional historic and forecast data; market share of competitors; market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

TABLE OF CONTENTS

1 Executive Summary
1.1 AI In Pharma – Market Attractiveness And Macro economic Landscape
2 Table Of Contents
3 List Of Tables
4 List Of Figures
5 Report Structure
6 Market Characteristics
6.1 General Market Definition
6.2 Summary
6.3 AI In Pharma Market Definition And Segmentations
6.4 Market Segmentation By Technology
6.4.1 Context-Aware Processing
6.4.2 Natural Language Processing
6.4.3 Querying Method
6.4.4 Deep Learning
6.5 Market Segmentation By Drug Type
6.5.1 Small Molecule
6.5.2 Large Molecules
6.6 Market Segmentation By Application
6.6.1 Diagnosis
6.6.2 Clinical Trial Research
6.6.3 Drug Discovery
6.6.4 Research And Development
6.6.5 Epidemic Prediction
7 Major Market Trends
7.1 Introduction Of Generative AI In Pharma To Improve Medical Consultations
7.2 Use Of AI In Molecular Target Identification
7.3 Integration Of AI In Drug Screening Process To Accelerate Drug Development
7.4 Growing Investments To Develop New Product Solutions
7.5 Strategic Partnerships And Collaborations Among Market Players
8 AI In Pharma Market – Macro Economic Scenario
8.1 COVID-19 Impact On The AI In Pharma Market
8.2 Impact Of The War In Ukraine On The AI In Pharma Market
8.3 Impact Of High Inflation On The AI In Pharma Market
9 Global Market Size and Growth
9.1 Market Size
9.2 Historic Market Growth, 2017 – 2022, Value ($ Million)
9.2.1 Market Drivers 2017 – 2022
9.2.2 Market Restraints 2017 – 2022
9.3 Forecast Market Growth, 2022 – 2027, 2032F Value ($ Million)
9.3.1 Market Drivers 2022 – 2027
9.3.2 Market Restraints 2022 – 2027
10 Global AI In Pharma Market Segmentation
10.1 Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
10.2 Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
10.3 Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
11 AI In Pharma Market, Regional and Country Analysis
11.1 Global AI In Pharma Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
11.2 Global AI In Pharma Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12 Asia-Pacific Market
12.1 Summary
12.1.1 Market Overview
12.1.2 Region Information
12.1.3 Market Information
12.1.4 Background Information
12.1.5 Government Initiatives
12.1.6 Regulations
12.1.7 Regulatory Bodies
12.1.8 Major Associations
12.1.9 Taxes Levied
12.1.10 Corporate Tax Structure
12.1.11 Investments
12.1.12 Major Companies
12.2 Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.3 Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.4 Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.5 Asia-Pacific AI In Pharma Market: Country Analysis
12.6 China Market
12.7 Summary
12.7.1 Market Overview
12.7.2 Country Information
12.7.3 Market Information
12.7.4 Background Information
12.7.5 Government Initiatives
12.7.6 Regulations
12.7.7 Regulatory Bodies
12.7.8 Major Associations
12.7.9 Taxes Levied
12.7.10 Corporate Tax Structure
12.7.11 Investments
12.7.12 Major Companies
12.8 China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.9 China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.10 China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.11 India Market
12.12 India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.13 India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.14 India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.15 Japan Market
12.16 Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.17 Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.18 Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.19 Australia Market
12.20 Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.21 Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.22 Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.23 Indonesia Market
12.24 Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.25 Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.26 Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.27 South Korea Market
12.28 South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.29 South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
12.30 South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13 Western Europe Market
13.1 Summary
13.1.1 Market Overview
13.1.2 Region Information
13.1.3 Market Information
13.1.4 Background Information
13.1.5 Government Initiatives
13.1.6 Regulations
13.1.7 Regulatory Bodies
13.1.8 Major Associations
13.1.9 Taxes Levied
13.1.10 Corporate Tax Structure
13.1.11 Investments
13.1.12 Major Companies
13.2 Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.3 Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.4 Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.5 Western Europe AI In Pharma Market: Country Analysis
13.6 UK Market
13.7 UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.8 UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.9 UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.10 Germany Market
13.11 Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.12 Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.13 Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.14 France Market
13.15 France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.16 France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
13.17 France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14 Eastern Europe Market
14.1 Summary
14.1.1 Market Overview
14.1.2 Region Information
14.1.3 Market Information
14.1.4 Background Information
14.1.5 Government Initiatives
14.1.6 Regulations
14.1.7 Regulatory Bodies
14.1.8 Major Associations
14.1.9 Taxes Levied
14.1.10 Corporate Tax Structure
14.1.11 Investments
14.1.12 Major Companies
14.2 Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.3 Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.4 Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.5 Eastern Europe AI In Pharma Market: Country Analysis
14.6 Russia Market
14.7 Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.8 Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
14.9 Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15 North America Market
15.1 Summary
15.1.1 Market Overview
15.1.2 Region Information
15.1.3 Market Information
15.1.4 Background Information
15.1.5 Government Initiatives
15.1.6 Regulations
15.1.7 Regulatory Bodies
15.1.8 Major Associations
15.1.9 Taxes Levied
15.1.10 Corporate Tax Structure
15.1.11 Investments
15.1.12 Major Companies
15.2 North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.3 North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.4 North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.5 North America AI In Pharma Market: Country Analysis
15.6 USA Market
15.7 Summary
15.7.1 Country Information
15.7.2 Market Information
15.7.3 Background Information
15.7.4 Government Initiatives
15.7.5 Regulations
15.7.6 Regulatory Bodies
15.7.7 Major Associations
15.7.8 Taxes Levied
15.7.9 Corporate Tax Structure
15.7.10 Investments
15.7.11 Major Companies
15.8 USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.9 USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
15.10 USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16 South America Market
16.1 Summary
16.1.1 Market Overview
16.1.2 Region Information
16.1.3 Market Information
16.1.4 Background Information
16.1.5 Government Initiatives
16.1.6 Regulations
16.1.7 Regulatory Bodies
16.1.8 Major Associations
16.1.9 Taxes Levied
16.1.10 Corporate Tax Structure
16.1.11 Investments
16.1.12 Major Companies
16.2 South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.3 South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.4 South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.5 South America AI In Pharma Market: Country Analysis
16.6 Brazil Market
16.7 Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.8 Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
16.9 Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17 Middle East Market
17.1 Summary
17.1.1 Market Overview
17.1.2 Region Information
17.1.3 Market Information
17.1.4 Background Information
17.1.5 Government Initiatives
17.1.6 Regulations
17.1.7 Regulatory Bodies
17.1.8 Major Associations
17.1.9 Taxes Levied
17.1.10 Corporate Tax Structure
17.1.11 Investments
17.1.12 Major Companies
17.2 Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17.3 Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
17.4 Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18 Africa Market
18.1 Summary
18.1.1 Market Overview
18.1.2 Region Information
18.1.3 Market Information
18.1.4 Background Information
18.1.5 Government Initiatives
18.1.6 Regulations
18.1.7 Regulatory Bodies
18.1.8 Major Associations
18.1.9 Taxes Levied
18.1.10 Corporate Tax Structure
18.1.11 Investments
18.1.12 Major Companies
18.2 Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18.3 Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
18.4 Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, Value ($ Million)
19 Competitive Landscape And Company Profiles
19.1 Company Profiles
19.2 Concerto HealthAI
19.2.1 Company Overview
19.2.2 Products And Services
19.2.3 Business Strategy
19.2.4 Financial Overview
19.3 Alphabet Inc.
19.3.1 Company Overview
19.3.2 Products And Services
19.3.3 Business Strategy
19.3.4 Financial Overview
19.4 OWKIN
19.4.1 Company Overview
19.4.2 Products And Services
19.4.3 Business Strategy
19.4.4 Financial Overview
19.5 Nvidia Corporation
19.5.1 Company Overview
19.5.2 Products And Services
19.5.3 Business Strategy
19.5.4 Financial Overview
19.6 PathAI
19.6.1 Company Overview
19.6.2 Products And Services
19.6.3 Business Strategy
19.6.4 Financial Overview
20 Key Mergers And Acquisitions
20.1 BioNTech Acquired InstaDeep
20.2 Recursion Pharmaceuticals Acquired Cyclica And Valence
20.3 Telix Pharmaceuticals Acquired Dedicaid GmbH
20.4 Envision Pharma Group Acquired OKRA.ai
20.5 Bayer AG Acquired Blackford Analysis Ltd
20.6 iBio Acquired Rubryc Therapeutics
20.7 Genentech Acquired Prescient Design
20.8 Nurosene Health Inc Acquired Netramark Incorporated
20.9 X-Chem Acquired Glamorous AI
21 Opportunities And Strategies
21.1 Global AI In Pharma Market In 2027 – Countries Offering Most New Opportunities
21.2 Global AI In Pharma Market In 2027 – Segments Offering Most New Opportunities
21.3 Global AI In Pharma Market In 2027 – Growth Strategies
21.3.1 Market Trend Based Strategies
21.3.2 Competitor Strategies
22 AI In Pharma Market, Conclusions And Recommendations
22.1 Conclusions
22.2 Recommendations
22.2.1 Product
22.2.2 Place
22.2.3 Price
22.2.4 Promotion
22.2.5 People
23 Appendix
23.1 Geographies Covered
23.2 Market Data Sources
23.3 Research Methodology
23.4 Currencies
23.5 The Business Research Company
23.6 Copyright and Disclaimer

List Of Tables

Table 1: Global AI In Pharma Market, Historic, 2017 – 2022, $ Million
Table 2: Global AI In Pharma Market, Forecast, 2022 – 2027, 2032F, $ Million
Table 3: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 4: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 5: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 6: Global AI In Pharma Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 7: Global AI In Pharma Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 8: Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 9: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 10: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 11: China GDP Per Capita, By Country, 2017-2022, $
Table 12: China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 13: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 14: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 15: India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 16: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 17: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 18: Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 19: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 20: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 21: Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 22: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 23: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 24: Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 25: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 26: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 27: South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 28: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 29: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 30: Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 31: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 32: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 33: UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 34: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 35: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 36: Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 37: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 38: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 39: France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 40: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 41: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 42: Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 43: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 44: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 45: Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 46: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 47: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 48: North America GDP Per Capita, By Country, 2017-2022, $
Table 49: North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 50: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 51: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 52: USA GDP Per Capita, By Country, 2017-2022, $
Table 53: USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 54: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 55: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 56: South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 57: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 58: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 59: Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 60: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 61: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 62: Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 63: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 64: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 65: Africa GDP Per Capita, By Country, 2017-2022, $
Table 66: Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 67: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 68: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Table 69: Global AI In Pharma Market, Key Competitor Estimated Market Shares, 2022, Percentage (%)
Table 70: Concerto HealthAI – Financial Overview, 2018 – 2022, $ Billion
Table 71: Alphabet Inc – Financial Overview, 2018 – 2022, $ Billion
Table 72: OWKIN – Financial Overview, 2018 – 2022, $ Billion
Table 73: NVIDIA Corporation – Financial Overview, 2018 – 2022, $ Billion
Table 74: PathAI – Financial Overview, 2018 – 2022, $ Billion
Table 75: Global AI In Pharma Market Size Gain ($ Million), 2022 – 2027, By Country
Table 76: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Technology, 2022 – 2027
Table 77: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Drug Type, 2022 – 2027
Table 78: Global AI In Pharma Market Size Gain ($ Million), Segmentation By Application, 2022 – 2027
Table 79: AI In Pharma Market Data Sources

List Of Figures

Figure 1: Global AI In Pharma Market Segmentation By Technology
Figure 2: Global AI In Pharma Market Segmentation By Drug Type
Figure 3: Global AI In Pharma Market Segmentation By Application
Figure 4: Global AI In Pharma Market, Historic, 2017 – 2022, $ Million
Figure 5: Global AI In Pharma Market, Forecast, 2022 – 2027, 2032F, $ Million
Figure 6: Global AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 7: Global AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 8: Global AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 9: Global AI In Pharma Market, By Region, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 10: Global AI In Pharma Market, By Country, Historic and Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 11: Asia-Pacific AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 12: Asia-Pacific AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 13: Asia-Pacific AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 14: China AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 15: China AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 16: China AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 17: India AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 18: India AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 19: India AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 20: Japan AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 21: Japan AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 22: Japan AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 23: Australia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 24: Australia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 25: Australia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 26: Indonesia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 27: Indonesia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 28: Indonesia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 29: South Korea AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 30: South Korea AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 31: South Korea AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 32: Western Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 33: Western Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 34: Western Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 35: UK AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 36: UK AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 37: UK AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 38: Germany AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 39: Germany AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 40: Germany AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 41: France AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 42: France AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 43: France AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 44: Eastern Europe AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 45: Eastern Europe AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 46: Eastern Europe AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 47: Russia AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 48: Russia AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 49: Russia AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 50: North America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 51: North America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 52: North America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 53: USA AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 54: USA AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 55: USA AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 56: South America AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 57: South America AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 58: South America AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 59: Brazil AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 60: Brazil AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 61: Brazil AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 62: Middle East AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 63: Middle East AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 64: Middle East AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 65: Africa AI In Pharma Market, Segmentation By Technology, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 66: Africa AI In Pharma Market, Segmentation By Drug Type, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 67: Africa AI In Pharma Market, Segmentation By Application, Historic And Forecast, 2017 – 2023, 2027F, 2032F, $ Million
Figure 68: Global AI In Pharma, Key Competitor Estimated Market Shares, 2022, Percentage (%)
Figure 69: Alphabet Inc – Financial Overview, 2018 – 2022, $ Billion
Figure 70: NVIDIA Corporation – Financial Overview, 2018 – 2022, $ Billion
Figure 71: Geographic Regions Covered